DNOW's Turnaround Narrative Confronts Another Quarter in the Red
DNOW Inc. reports second-quarter 2026 earnings before market open on August 6, with analysts expecting $0.08 per share—a sharp 70% decline from the $0.27 earned in the same quarter last year. The central question is whether the energy equipment distributor can stabilize operations after last quarter's stunning 80% earnings miss, which sent shares tumbling and raised concerns about ongoing ERP integration challenges. With the stock now trading at $14.22 and analysts maintaining strong buy ratings despite the recent stumble, investors face a critical test of whether management's turnaround narrative can translate into actual results.
Part 1: Earnings Preview
DNOW Inc. is a leading distributor of energy and industrial products, serving upstream, midstream, and downstream sectors through its DistributionNOW and DNOW Process Solutions segments. The company provides pipe, valves, fittings, and mill supplies to oil and gas operators globally. The Houston-based distributor is scheduled to report Q2 2026 results before market open on August 6, with consensus calling for $0.08 per share on revenue estimates of approximately $1.27 billion from 3 analysts (range: $0.07–$0.09). Most recently, DNOW reported Q1 2026 EPS of $0.01, a dramatic miss that fell 80% short of the $0.05 consensus. Year-over-year, the Q2 estimate represents a 70% decline from the $0.27 earned in Q2 2025, reflecting the severe operational headwinds that emerged this year.
Three key themes define this earnings story:
ERP Integration Fallout: The company's U.S. segment posted a $54 million operating loss in Q1 as enterprise resource planning system integration issues from the MRC Global acquisition disrupted operations and pressured margins. Investors are watching whether these technology challenges have been resolved or continue to weigh on profitability.
Margin Recovery Path: Adjusted EBITDA collapsed to just 3.3% margin ($39 million) in Q1 as integration costs mounted. Management's ability to demonstrate sequential margin improvement will be critical to restoring confidence in the business model.
Acquisition Synergy Timeline: The Edge Controls acquisition was completed to strengthen Process Solutions offerings, but the MRC Global integration continues causing revenue headwinds. Analysts are focused on when synergies will materialize and whether the company can return to its historical earnings power.
Analyst commentary ahead of the release reflects cautious optimism tempered by recent execution concerns. While 5 of 6 analysts maintain strong buy ratings with a $16 mean price target (12% upside), estimates have been revised sharply lower—the Q2 consensus has dropped from $0.16 ninety days ago to just $0.08 today. Management's Q3 guidance of $0.18 per share and full-year projection of $0.62 suggest they expect conditions to improve as ERP stabilization progresses, but investors will demand concrete evidence that the worst is behind them.
Part 2: Historical Earnings Performance
DNOW's recent earnings track record reveals a company that consistently exceeded expectations until a dramatic reversal in the most recent quarter. Over the four quarters shown, the company beat estimates in three consecutive reports—posting surprises of +22.73% in Q2 2025 ($0.27 vs. $0.22 expected), +8.33% in Q3 2025 ($0.26 vs. $0.24), and +25.00% in Q4 2025 ($0.15 vs. $0.12). This pattern of reliable outperformance established DNOW as an execution story that delivered above consensus.
That narrative shattered in Q1 2026 when the company reported just $0.01 against a $0.05 estimate—an -80.00% miss that marked the worst quarterly performance in the dataset. The magnitude of the shortfall, driven by ERP integration issues and a $54 million U.S. segment operating loss, represents a complete departure from the company's prior consistency. The sequential collapse from $0.15 to $0.01 in earnings underscores the severity of operational disruption.
The pattern suggests DNOW historically possessed strong operational execution and visibility, making the Q1 miss all the more jarring for investors. The key question heading into Q2 is whether last quarter was an isolated integration-related stumble or signals deeper structural challenges. With estimates now reset dramatically lower at $0.08 (down from $0.27 a year ago), the bar has been lowered significantly—but investor confidence remains fragile after such a significant execution failure.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $0.22 | $0.27 | +22.73% | Beat |
| Sep 2025 | $0.24 | $0.26 | +8.33% | Beat |
| Dec 2025 | $0.12 | $0.15 | +25.00% | Beat |
| Mar 2026 | $0.05 | $0.01 | -80.00% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
DNOW typically reports earnings before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-07 | -$0.45 (-3.33%) | $0.77 (5.70%) | +$0.02 (+0.15%) | $0.51 (3.91%) |
| 2026-02-20 | -$3.13 (-19.13%) | $2.46 (15.04%) | -$1.38 (-10.43%) | $1.31 (9.90%) |
| 2025-11-05 | -$0.04 (-0.27%) | $2.93 (20.10%) | -$0.99 (-6.80%) | $1.60 (10.95%) |
| 2025-08-06 | -$1.14 (-7.48%) | $2.52 (16.54%) | +$0.77 (+5.46%) | $0.85 (6.03%) |
| 2025-05-07 | -$1.37 (-8.55%) | $1.69 (10.54%) | -$0.12 (-0.82%) | $0.91 (6.21%) |
| 2025-02-13 | +$2.84 (+20.08%) | $2.23 (15.77%) | +$0.20 (+1.18%) | $0.88 (5.18%) |
| 2024-11-07 | -$0.01 (-0.07%) | $1.27 (9.24%) | +$0.51 (+3.71%) | $0.88 (6.40%) |
| 2024-08-07 | -$0.62 (-4.41%) | $1.46 (10.35%) | -$0.62 (-4.61%) | $0.63 (4.72%) |
| Avg Abs Move | 7.92% | 12.91% | 4.15% | 6.66% |
Historical price behavior shows DNOW exhibits significant volatility around earnings, with an average absolute Day 0 move of 7.92% and Day +1 follow-through averaging 4.15%. The most dramatic reaction came in February 2026, when shares plunged -19.13% on Day 0 following the Q4 2025 report, then continued lower with a -10.43% Day +1 move—reflecting the market's severe negative reaction to deteriorating fundamentals. The most recent Q1 2026 report in May produced a relatively muted -3.33% Day 0 decline, suggesting much of the bad news may have already been priced in by that point.
The data reveals asymmetric risk, with several large negative reactions (February 2026's -19%, August 2025's -7.5%, May 2025's -8.6%) contrasting against only one significant positive move (February 2025's +20% surge). Day 0 trading ranges average 12.91%, indicating substantial intraday volatility regardless of direction. Investors should prepare for meaningful price movement, particularly given the uncertainty around whether operational issues have been resolved. The historical pattern suggests the market reacts decisively to any signs of execution problems, while rewarding clear evidence of improvement with sharp rallies.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 16) |
| Expected Move | $1.19 (8.36%) |
| Expected Range | $13.04 to $15.42 |
| Implied Volatility | 54.28% |
The options market is pricing an 8.36% expected move through the August 21 expiration (16 days out), which sits slightly above the 7.92% average Day 0 move but well below the 12.91% average Day 0 range seen historically. This suggests options traders are anticipating moderate volatility—less dramatic than the February 2026 blowup but still meaningful given the company's recent execution challenges and the need to demonstrate operational stabilization.
Part 3: What Analysts Are Saying
Analyst sentiment remains surprisingly bullish despite recent operational stumbles, with 5 strong buy ratings and 1 hold among the 6 analysts covering DNOW, producing an average recommendation of 4.67 out of 5.0. The consensus price target sits at $16.00, with a tight range from $15.00 to $17.00, implying 12.5% upside from the current $14.22 price. This suggests analysts view the Q1 miss as a temporary integration-related setback rather than a fundamental deterioration in the business model.
However, the unchanged sentiment trend over the past month masks significant estimate revisions beneath the surface. While rating counts have held steady, earnings estimates have been slashed dramatically—the Q2 2026 consensus has plummeted from $0.16 just 90 days ago to $0.08 today, a 50% reduction. Full-year 2026 estimates have similarly collapsed from $1.04 to $0.31, reflecting analysts' acknowledgment that integration challenges will suppress profitability throughout the year.
The analyst community appears to be taking a longer-term view, maintaining buy ratings based on 2027 recovery expectations. Next year's consensus of $0.84 per share represents a +170.97% growth estimate from 2026's depressed $0.31 baseline, suggesting analysts believe operational issues will be resolved and the company will return to normalized earnings power. The key debate is whether this optimistic 2027 outlook is realistic or whether integration challenges prove more persistent than currently modeled. The tight price target range indicates relatively high conviction in the $15–17 valuation zone, but the dramatic estimate cuts reveal significant uncertainty about the near-term earnings trajectory.
Part 4: Technical Picture
DNOW enters earnings with strengthening technical momentum after recovering from its Q1 miss. The Barchart Technical Opinion currently shows an 88% Buy signal, a dramatic improvement from the 56% Sell reading just one month ago and the 24% Buy signal last week. This rapid shift reflects the stock's ability to stabilize and build positive momentum heading into the Q2 report.
Timeframe Analysis:
- Short-term (100% Buy): Maximum bullish signal indicates strong near-term momentum as the stock has rallied into earnings
- Medium-term (100% Buy): Equally strong intermediate-term reading suggests the recovery from May's lows has established a positive trend
- Long-term (50% Buy): Moderate bullish signal reflects lingering caution about the longer-term trajectory given recent execution challenges
The trend is characterized as Average strength but Strengthening direction, indicating momentum is building but not yet at maximum conviction levels—appropriate given the company's need to prove operational stabilization.
The stock is trading at $14.22, positioned above all key moving averages: the 5-day ($14.15), 10-day ($14.09), 20-day ($13.84), 50-day ($13.51), 100-day ($12.98), and 200-day ($13.46). This clean technical setup with price above all major averages provides a supportive foundation heading into the release.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $14.15 | 50-Day MA | $13.51 |
| 10-Day MA | $14.09 | 100-Day MA | $12.98 |
| 20-Day MA | $13.84 | 200-Day MA | $13.46 |
The ascending moving average structure—with shorter-term averages above longer-term ones—confirms an uptrend is in place, though the modest separation between levels suggests the rally remains in early stages. The stock has climbed approximately 9.5% from its 100-day moving average at $12.98, indicating a meaningful recovery from post-Q1 lows but not yet extended into overbought territory. The technical setup is cautiously supportive for earnings, with momentum indicators aligned positively but the stock not yet priced for perfection. A beat-and-raise scenario could trigger a breakout above $15 toward analyst targets, while any disappointment risks a quick retreat back toward the $13.50 support zone where the 50-day and 200-day averages converge. The key will be whether management can deliver results that validate the recent technical recovery and justify the bullish analyst outlook.